{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-22-002068","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.026876+00:00","generated_at":"2026-06-21T11:38:06.180618+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enochian BioSciences receives second Nasdaq delisting notice over delayed 10-Q filing","bullets":["Nasdaq notified Enochian on Nov 23, 2022, of non-compliance with Listing Rule 5250(c)(1) for failure to file Form 10-Q for period ended Sep 30, 2022.","This follows a prior notice on Oct 17, 2022, for delayed Form 10-K (year ended Jun 30, 2022).","Delay attributed to ongoing work by a third-party valuator on a company asset.","Company must submit a compliance plan by Dec 16, 2022; if accepted, Nasdaq may grant until Apr 11, 2023 to file.","Failure to regain compliance could lead to delisting from Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-22-002068","json":"https://secwatch.observer/filing/0001731122-22-002068.json","markdown":"https://secwatch.observer/filing/0001731122-22-002068.md","text":"https://secwatch.observer/filing/0001731122-22-002068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/0001731122-22-002068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/e4267_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:38:06.180618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51c178be3f3b8869567cf4794a7c2739bb025c4f","claim":"Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"November 23, 2022, Enochian Biosciences Inc. (the “ Company ”) received a notice (the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”)stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “ Form 10-Q ”), the Company remains in non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. As previously disclosed on Form 8-K filed with the Securities and Exchange Commission on October 21, 2022, on October 1","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/0001731122-22-002068-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}